SP Group (SPG) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
16 Sep, 2026Executive summary
Achieved record revenue in 2024, with strong growth in proprietary products and improved margins.
Proprietary products, especially in healthcare and cleantech, were key growth drivers.
Strategic focus on expanding through acquisitions and increasing sustainability initiatives.
Financial highlights
Revenue increased by 12.1% year-over-year to DKK 2,922 million in 2024.
EBITDA rose 33.5% to DKK 589 million, with an EBITDA margin of 20.1%.
EBT surged 71.5% to DKK 345 million, with an EBT margin of 11.8%.
EPS increased to DKK 21.6 from DKK 13.0 in 2023.
Operating cash flow reached DKK 510 million, up from DKK 360 million in 2023.
Outlook and guidance
2025 revenue growth expected in the range of 3-10%.
EBITDA margin guidance for 2025 is 19-21%; EBT margin expected at 11-13%.
Long-term ambition for 2030: revenue of DKK 4.5 billion, EBT of DKK 600 million, and annual revenue growth of 6-9%.
Latest events from SP Group
- Record H1 2026 growth and UK expansion led to upgraded outlook and strong margins.SPG
Q2 2026 - Record H1 2026 revenue and earnings growth led to an upgraded full-year outlook.SPG
Q2 2026 - Record Q1 2026 growth, robust outlook, and active capital returns amid global uncertainty.SPG
Q1 2026 - Record Q1 2026 revenue and profit growth, outlook and guidance remain robust.SPG
Q1 2026 - Record Q4 and strong 2026 growth outlook, boosted by Idé-Pro acquisition.SPG
Q4 2025 - Record Q4 and Idé-Pro acquisition set stage for strong 2026 growth amid ongoing uncertainties.SPG
Q4 2025 - H1 2025 saw lower sales and earnings, but margins and full-year outlook remain stable.SPG
Q2 2025 - Strong H1 2024 growth, upgraded outlook, and international expansion led by healthcare sales.SPG
Q2 2024 - Q1 2025 saw 8.8% revenue growth, strong margins, and robust Healthcare segment gains.SPG
Q1 2025